NCT02314884View on ClinicalTrials.gov

Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours

PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Neoplasms
Interventions
DRUG

Cafusertib Hydrochloride

Trial Locations (1)

Unknown

RECRUITING

Beijing Cancer Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY